<DOC>
	<DOCNO>NCT02271529</DOCNO>
	<brief_summary>The objective study evaluate performance Zilver PTX stent thumbwheel delivery system .</brief_summary>
	<brief_title>Zilver PTX Delivery System</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>Patient symptomatic vascular disease native abovetheknee femoropopliteal artery Patient atherosclerotic lesion abovetheknee femoropopliteal artery Patient &lt; 18 year age Patient unable complete require followup assessment Patient unwilling sign date inform consent Simultaneous participation another investigational drug device study Pregnant , breastfeed plan become pregnant next 5 year Additional medical/anatomical restriction specify Clinical Investigation Plan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Peripheral Vascular Disease</keyword>
	<keyword>Femoral Artery</keyword>
	<keyword>Drug-Eluting Stent</keyword>
</DOC>